Technical Analysis for NOVN - Novan, Inc.

Grade Last Price % Change Price Change
grade D 2.388 -2.27% -0.06
NOVN closed up 1.39 percent on Monday, October 14, 2019, on 35 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: Nov 1

*** please verify all earnings dates ***
1 Watcher
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical NOVN trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish -2.27%
Oversold Stochastic Weakness -2.27%
50 DMA Resistance Bearish -0.91%
Inside Day Range Contraction -0.91%
Oversold Stochastic Weakness -0.91%
50 DMA Resistance Bearish 2.05%
Expansion Pivot Sell Setup Bearish Swing Setup 2.05%
Stochastic Reached Oversold Weakness 2.05%
Below Lower BB Weakness 2.05%
Lower Bollinger Band Touch Weakness 2.05%

Older signals for NOVN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
NOVN Chart by TradingView
Basic chart:
Profile
Novan, Inc. is a late-stage pharmaceutical company. The Company is engaged in the development and commercialization of therapies using its nitric oxide platform. The Company develops product candidates using its Nitricil technology, which enables the Company to engineer tunable new chemical entities (NCEs). The Company's formulation science enables it to further tune the release of nitric oxide when applied to the skin by using the combinations of inactive ingredients. It is developing SB204 for the treatment of acne vulgaris in Phase III. The Company is developing its product candidate, SB206, for the treatment of external genital and perianal warts in Phase II. It is developing SB208, an investigational topical anti-fungal for the treatment of fungal infections of the skin and nails. It is developing SB204 for the treatment of inflammatory skin diseases. Its pipeline also includes SB414, a topical cream product candidate.
Medical Specialties Organ Systems Infectious Diseases Acne Product Candidates Acne Vulgaris Cutaneous Conditions Fungal Infections Inflammatory Skin Diseases Treatment Of Inflammatory Skin Diseases Wart
Is NOVN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Oct 8 Novan’s Phase 2 SB206 Molluscum Study Published in Journal of the American Academy of Dermatology
Sep 20 Novan nabs DoD grant to support development of cancer candidate
Sep 20 Novan Awarded Approximately $1.1 Million Grant by Department of Defense
Sep 16 Novan (NOVN) Presents At H.C. Wainwright 21st Annual Global Investment Conference - Slideshow
Sep 11 Novan Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Sep 6 86 Biggest Movers From Yesterday
Sep 5 Triangle pharma strikes deal to sell up to $25M of its stock
Sep 5 Healthcare - Top 5 Gainers / Losers
Sep 5 Novan inks $25M stock purchase deal with Aspire
Sep 3 Novan Hires Michelle Patterson as Vice President of Project Management
See more NOVN news...
Indicators
Indicator Value
52 Week High 3.02
52 Week Low 0.65
Average Volume 66,652
200-Day Moving Average 1.893
50-Day Moving Average 2.5275
20-Day Moving Average 2.6027
10-Day Moving Average 2.5004
Average True Range 0.1768
ADX 19.51
+DI 8.8737
-DI 18.0425
Chandelier Exit (Long, 3 ATRs ) 2.4696
Chandelier Exit (Short, 3 ATRs ) 2.8404
Upper Bollinger Band 2.8553
Lower Bollinger Band 2.3501
Percent B (%b) 0.18
BandWidth 19.410612
MACD Line -0.0396
MACD Signal Line -0.0099
MACD Histogram -0.0297
Fundamentals Value
Market Cap 39.06 Million
Num Shares 16 Million
EPS -4.08
Price-to-Earnings (P/E) Ratio -0.60
Price-to-Sales 129.29
Price-to-Book 8.46
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.59
Resistance 3 (R3) 2.59 2.54 2.57
Resistance 2 (R2) 2.54 2.50 2.54 2.56
Resistance 1 (R1) 2.49 2.48 2.52 2.49 2.55
Pivot Point 2.44 2.44 2.45 2.44 2.44
Support 1 (S1) 2.39 2.40 2.42 2.39 2.34
Support 2 (S2) 2.34 2.38 2.34 2.33
Support 3 (S3) 2.29 2.34 2.32
Support 4 (S4) 2.29